Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
about
Current and emerging treatment options in the management of lupusHydroxychloroquine-related retinal toxicityAn Update on Treatment and Management of Pediatric Systemic Lupus ErythematosusHydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus.Chloroquine cardiomyopathy - a review of the literature.Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-upSystemic lupus erythematosus: review of synthetic drugs.Pre-dose plasma concentration monitoring of mycophenolate mofetil in patients with autoimmune diseases.Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma.Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized.Hydroxychloroquine Protects against Cardiac Ischaemia/Reperfusion Injury In Vivo via Enhancement of ERK1/2 PhosphorylationVery low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosusCharacteristics of azathioprine use and cessation in a longitudinal lupus cohort.Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence.Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosusEndosomal Toll-like receptors in clinically overt and silent autoimmunity.Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block.Lupus in adolescence.A perspective on B-cell-targeting therapy for SLE.Pediatric SLE--towards a comprehensive management plan.Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.The role of antimalarial agents in the treatment of SLE and lupus nephritis.Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.Hydroxychloroquine and smoking in patients with cutaneous lupus erythematosus.New insights into mechanisms of therapeutic effects of antimalarial agents in SLE.Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.Therapeutic drug monitoring in rheumatic diseases: utile or futile?A Critical Review of the Effects of Hydroxychloroquine and Chloroquine on the Eye.Optimizing the use of existing therapies in lupus.Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus.Development and validation of a clinical HPLC method for the quantification of hydroxychloroquine and its metabolites in whole blood.New Perspectives in Rheumatology: Avoiding Antimalarial Toxicity.Immunomodulators in SLE: Clinical evidence and immunologic actions.Therapeutic monitoring of the immuno-modulating drugs in systemic lupus erythematosus.Hydroxychloroquine in systemic lupus erythematosus (SLE).It hasn't gone away: the problem of glucocorticoid use in lupus remains.Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels.Drugs used in incident systemic lupus erythematosus - results from the Finnish nationwide register 2000-2007.Factors Related to Blood Hydroxychloroquine Concentration in Patients With Systemic Lupus Erythematosus.
P2860
Q26741266-05348F8C-9554-4369-8B88-3359BE649497Q26782822-899DC856-1A6E-462B-98B8-5599CD7E7D9AQ28074348-1008E352-9207-46E3-BCE6-441AC7DD4EDDQ33411608-56B689F8-A304-42AB-A710-0EEAC89BDAA6Q33422958-E226A740-EE8E-4973-A938-F9732994ADD1Q34342236-5A86868B-0EEE-46B5-9138-383C2AAC5E80Q34424653-E61B423B-1981-422B-A60B-FC6117C053C8Q34498515-10299566-0CCC-4C7C-A046-41FD5C1C2B3EQ34635584-210F4121-5BAD-4029-933F-27AC1572926BQ35686749-43624012-3BA3-41A1-9339-24D418E20E24Q35752523-C14ADBEF-3A45-41F3-9F86-98B7C205B1B4Q35860938-EBDA2662-63AA-41DB-B8F7-DC57E49E8C7AQ35953424-60D8FA7E-B121-4DB5-BD90-908C94A2AB22Q35992235-55BBED09-491F-471F-B359-A25B3A664B06Q36240425-B29BA533-CF00-4F7B-9921-62A195320408Q36246166-5ADEF5EB-30BC-4824-B83C-DA091924B7CCQ36389926-A5E09C1E-DA32-419A-887B-2E8C5AE2AEEEQ36577968-4D8AEA0E-9EB1-4D42-B242-F6634E4470BCQ36915654-1AB03904-76C9-44E6-A95B-36041DB094AFQ37577571-73FB8243-0981-42E1-9358-B601429CBE3EQ37850999-D2191D2E-4AA7-4A5B-89AD-EAF82EA001D0Q37854742-A67EC124-AB38-4DEA-8C24-B5E92AC677F6Q37947108-C1AB0099-7135-4C05-BA92-A8425C335E28Q37977481-BEE27C6D-98AC-4264-80FB-D1F16C71F733Q38009852-753D5851-EA72-49B9-A3B8-3F0966937EDBQ38026787-6C441B5C-A368-471F-9EA4-AF60697C87B6Q38029146-AA2687D8-6043-4822-A97D-0FACB1CAA3D5Q38160305-716BB345-D28C-4DB6-86CF-A6949D854E47Q38352048-8D52AD72-3667-45F0-B11C-131BFD52FBD2Q38425824-F41F0F85-7BDA-4EEA-9901-C5161DEFB252Q38634472-6D4CFFCA-403B-4391-9626-260872CEDA78Q38776952-4327529C-620F-41F5-B156-D3245B30BE21Q38816742-B3CDB32C-244F-4C96-A742-9C5ED6C51579Q38883883-48C3C0FB-846F-4DD6-A0C5-21A1C1C6DFA7Q38897055-A3C1A45F-F982-4797-9D86-E357B74ED656Q39031764-7CE61A21-4882-46B9-8BC3-391B1440BAC6Q39053147-AD6B1A83-F241-4C70-8F03-49D70DE12225Q39997361-454DC82A-CDDB-4EF0-8E5A-43DDFEFB9729Q40047389-6C3F5AF9-E33E-47B8-A907-D9DD883B857DQ41914711-7F77573F-EAF8-4368-BD32-CED6EBFA3AFF
P2860
Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Low blood concentration of hyd ...... systemic lupus erythematosus.
@en
type
label
Low blood concentration of hyd ...... systemic lupus erythematosus.
@en
prefLabel
Low blood concentration of hyd ...... systemic lupus erythematosus.
@en
P2093
P50
P356
P1476
Low blood concentration of hyd ...... systemic lupus erythematosus.
@en
P2093
Bertrand Wechsler
Camille Francès
Du Le Thi Huong
Guy Aymard
Hala Abou Hammoud
Lucile Musset
Pascale Ghillani
Philippe Lechat
P304
P356
10.1002/ART.22156
P577
2006-10-01T00:00:00Z